Sequenta Garners New Funding Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    400 East Jamie Court South San Francisco, CA 94080 USA
  • Company Description
    Sequenta is a venture funded biotech company dedicated to the discovery and development of clinical diagnostics based on a revolutionary new platform for understanding immune system status.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    This financing, in addition to funding secured from several other strategic investors, will support incorporation of the ClonoSIGHT minimal residual disease (MRD) test into clinical trials of medicines in development for various hematological malignancies (blood cancers) and development of new clinical diagnostics based on Sequenta’s revolutionary LymphoSIGHT platform.
  • M&A Terms
  • Venture Investor
  • Venture Investor

Trending on Xconomy